Literature DB >> 17697212

The utility of B-type natriuretic peptide in predicting postoperative cardiac events and mortality in patients undergoing major emergency non-cardiac surgery.

B H Cuthbertson1, G Card, B L Croal, J McNeilly, G S Hillis.   

Abstract

B-type natriuretic peptide (BNP) levels predict cardiovascular risk in several settings. We hypothesised that they would identify individuals at increased risk of complications and mortality following major emergency non-cardiac surgery. Forty patients were studied with a primary end-point of a new postoperative cardiac event, and/or development of significant ECG changes, and/or cardiac death. The main secondary outcome was all-cause mortality at 6 months. Pre-operative BNP levels were higher in 11 patients who suffered a new postoperative cardiac event (p = 0.001) and predicted this outcome with an area under the receiver operating characteristic curve of 0.85 (CI = 0.72-0.98, p = 0.001). A pre-operative BNP value > 170 pg x ml(-1) has a sensitivity of 82% and a specificity of 79% for the primary end-point. In this small study, pre-operative BNP levels identify patients undergoing major emergency non-cardiac surgery who are at increased risk of early postoperative cardiac events. Larger studies are required to confirm these data.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17697212     DOI: 10.1111/j.1365-2044.2007.05146.x

Source DB:  PubMed          Journal:  Anaesthesia        ISSN: 0003-2409            Impact factor:   6.955


  6 in total

Review 1.  Perioperative Biomarkers Predicting Postoperative Atrial Fibrillation Risk After Coronary Artery Bypass Grafting: A Narrative Review.

Authors:  Muhammad S Khan; Kennosuke Yamashita; Vikas Sharma; Ravi Ranjan; Craig H Selzman; Derek J Dosdall
Journal:  J Cardiothorac Vasc Anesth       Date:  2019-09-18       Impact factor: 2.628

Review 2.  The comparative and added prognostic value of biomarkers to the Revised Cardiac Risk Index for preoperative prediction of major adverse cardiac events and all-cause mortality in patients who undergo noncardiac surgery.

Authors:  Lisette M Vernooij; Wilton A van Klei; Karel Gm Moons; Toshihiko Takada; Judith van Waes; Johanna Aag Damen
Journal:  Cochrane Database Syst Rev       Date:  2021-12-21

3.  Utility of B-type natriuretic Peptide for predicting perioperative cardiovascular events in patients without history of cardiovascular disease undergoing major non-cardiac surgery.

Authors:  Sung Eun Kim; Dae-Gyun Park; Jun Hee Lee; Kyoo Rok Han; Dong Jin Oh
Journal:  Korean Circ J       Date:  2011-01-31       Impact factor: 3.243

4.  Measurement of Exercise Tolerance before Surgery (METS) study: a protocol for an international multicentre prospective cohort study of cardiopulmonary exercise testing prior to major non-cardiac surgery.

Authors:  Duminda N Wijeysundera; Rupert M Pearse; Mark A Shulman; Tom E F Abbott; Elizabeth Torres; Bernard L Croal; John T Granton; Kevin E Thorpe; Michael P W Grocott; Catherine Farrington; Paul S Myles; Brian H Cuthbertson
Journal:  BMJ Open       Date:  2016-03-11       Impact factor: 2.692

Review 5.  Cardiopulmonary Exercise Testing and Other Tests of Functional Capacity.

Authors:  Marissa Ferguson; Mark Shulman
Journal:  Curr Anesthesiol Rep       Date:  2021-11-20

6.  Bridge to surgery using a self-expandable metallic stent for stages II-III obstructive colorectal cancer.

Authors:  Katsuya Ohta; Masakazu Ikenaga; Masami Ueda; Kiyotsugu Iede; Yujiro Tsuda; Shinsuke Nakashima; Takashi Nojiri; Jin Matsuyama; Shunji Endo; Jun Murata; Ichizo Kobayashi; Masahiko Tsujii; Terumasa Yamada
Journal:  BMC Surg       Date:  2020-08-20       Impact factor: 2.102

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.